Turkish Cargo reaches pharma transport milestone

By Damian Brett

Turkish Cargo is celebrating the carriage of medical and pharma products over the last 25 years.

The cargo business has carried Turkey’s medicine and medical products to over 50 countries in five continents over that period of time.

Today, Turkish Cargo boasts an 8% market share in the transportation of pharma as air cargo.

The airline highlighted its partnership with Eczacıbaşı-Monrol Nuclear Products, which started in 1995.

The pharma company specialises in the production of nuclear medicine for the treatment of cancer that require specialist handling.

Its products are flown by CEIV Pharma accredited Turkish Cargo to Germany, Colombia, India, Algeria and Taiwan, amongst other countries.

Eczacıbaşı-Monrol Nuclear Products General Manager Aydın Küçük said: As Turkey’s first radiopharmaceutical manufacturer, we are one of the significant producers of nuclear medicine for cancer treatment in the world and we export our products to over 50 countries.

“We can deliver these successes to patients all around the world from Europe, Africa, America and Far East thanks to our strong logistical operation. With this in mind, Turkish Cargo is one of our strongest supporters since 1995 with its speed, operational quality and wide transportation network.”

Share this story

Related Topics

Latest uncategorized news

Lufthansa Cargo doubles Vietnam capacity with Hanoi freighter service

By Damian Brett

Lufthansa Cargo has added Hanoi as a new destination to its B777 freighter network as it looks to capitalise on…

Read More

Share this story

Larry Coyne and Olivier Bijaoui join the TIACA Hall of Fame

The International Air Cargo Association (TIACA) has inducted Larry Coyne and Olivier Bijaoui into the Hall of Fame today during…

Read More

Share this story

Atlas Air sees profits and volumes slide due to Covid cases and hurricane Ian

By Damian Brett

Atlas Air Worldwide Holdings saw its profits and volumes decline in the third quarter of the year due to a…

Read More

Share this story